开能健康：副董事长瞿亚明当选原能细胞科技集团董事长

Group 1 - The core point of the article is that KaiNeng Health has appointed its Vice Chairman, Qu Yaming, as the Chairman of YuanNeng Cell Technology Group, which is expected to enhance the company's post-investment management of YuanNeng Group and align with the interests of the company and all shareholders [1] Group 2 - The appointment of Qu Yaming as Chairman was approved by the shareholders' meeting, indicating compliance with relevant laws, regulations, and the company's articles of association [1] - This leadership change is seen as a strategic move to strengthen the company's governance and oversight of its investments in YuanNeng Group [1]